SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-080422
Filing Date
2014-11-13
Accepted
2014-11-13 16:31:56
Documents
3
Period of Report
2014-11-10
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-23874_28k.htm 8-K 38346
2 EX-99.1 a14-23874_2ex99d1.htm EX-99.1 8602
3 EX-99.2 a14-23874_2ex99d2.htm EX-99.2 11955
  Complete submission text file 0001104659-14-080422.txt   60148
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 141218837
SIC: 2834 Pharmaceutical Preparations